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Abstract
Background:  Injection overuse and unsafe injection practices facilitate transmission of bloodborne
pathogens such as hepatitis B virus (HBV), hepatitis C virus (HCV), and human immunodeficiency virus
(HIV). Anecdotal reports of unsafe and unnecessary therapeutic injections and the high prevalence of HBV
(8.0%), HCV (6.5%), and HIV (2.6%) infection in Cambodia have raised concern over injection safety. To
estimate the magnitude and patterns of such practices, a rapid assessment of injection practices was
conducted.
Methods: We surveyed a random sample of the general population in Takeo Province and convenience
samples of prescribers and injection providers in Takeo Province and Phnom Penh city regarding injection-
related knowledge, attitudes, and practices. Injection providers were observed administering injections.
Data were collected using standardized methods adapted from the World Health Organization safe
injection assessment guidelines.
Results: Among the general population sample (n = 500), the overall injection rate was 5.9 injections per
person-year, with 40% of participants reporting receipt of ≥  1 injection during the previous 6 months.
Therapeutic injections, intravenous infusions, and immunizations accounted for 74%, 16% and 10% of
injections, respectively. The majority (>85%) of injections were received in the private sector. All
participants who recalled their last injection reported the injection was administered with a newly opened
disposable syringe and needle. Prescribers (n = 60) reported that 47% of the total prescriptions they wrote
included a therapeutic injection or infusion. Among injection providers (n = 60), 58% recapped the syringe
after use and 13% did not dispose of the used needle and syringe appropriately. Over half (53%) of the
providers reported a needlestick injury during the previous 12 months. Ninety percent of prescribers and
injection providers were aware HBV, HCV, and HIV were transmitted through unsafe injection practices.
Knowledge of HIV transmission through "dirty" syringes among the general population was also high (95%).
Conclusion: Our data suggest that Cambodia has one of the world's highest rates of overall injection
usage, despite general awareness of associated infection risks. Although there was little evidence of reuse
of needles and syringes, support is needed for interventions to address injection overuse, healthcare
worker safety and appropriate waste disposal.
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Background
In many developing countries and countries with econo-
mies in transition, health care injections are overused and
are frequently administered in an unsafe manner [1,2].
The World Health Organization (WHO) estimates that 20
million new hepatitis B virus (HBV) infections, 2 million
new hepatitis C virus (HCV) infections, and 260,000 new
HIV infections are associated with unsafe injections each
year worldwide [3].
Concerns have been expressed over the use of injections
within the Kingdom of Cambodia (2003 United Nations
population estimate 14.1 million). Anecdotal reports sug-
gest that therapeutic injections are often unnecessary and
administered in an unsafe manner, and healthcare waste
is inappropriately disposed [4-6]. A high prevalence of
HIV infection has been documented in Cambodia, with
2.6% of the general population infected [7]. Cambodia
also has high levels of HBV and HCV infection endemic-
ity. A 1991 community-based study indicated that 8.0%
of the population was hepatitis B surface antigen positive
and 6.5% was anti-HCV positive [8]. The proportion of
bloodborne pathogen infections in Cambodia attributa-
ble to unsafe injections is not known.
To estimate the magnitude and patterns of unsafe injec-
tion practices in Cambodia, a rapid assessment of injec-
tion practices was conducted. The objectives of the
assessment were to describe healthcare injection practices,
including measures of injection frequency and injection
safety, and determine knowledge, attitudes and practices
related to medical injections among the general popula-
tion and healthcare providers. This assessment focused
mainly on the unregulated private healthcare sector, in
which 70% of Cambodians seek medical care [9].
Methods
Overview
The assessment was conducted using methods established
by WHO for the rapid assessment of injection practices
[10]. As detailed in the following sections, we interviewed
members of the general population, healthcare workers
responsible for prescribing injections (i.e., "prescribers"),
and healthcare workers responsible for administering
injections (i.e., "injection providers"). All data were col-
lected during face-to-face interviews using standardized
questionnaires and forms adapted from the WHO assess-
ment guide [10]. The general population sample was
drawn from Takeo province (1998 population census
790,168), a rural province located in southeastern Cam-
bodia near the Vietnamese border. Prescribers and injec-
tion providers were sampled in Takeo province and in
Phnom Penh (1998 population census 999,809), Cambo-
dia's largest city [11].
General population
We surveyed 500 Takeo province residents in November
and December 2002 using standard cluster sampling
methodology. To obtain a total of 500 participants, we
surveyed 25 participants each in the catchment area of 20
district health centers. The 20 district health centers were
selected by probabilities proportional to the population
size of their catchment areas [12]. For each health center
selected, one village was chosen at random to be surveyed.
Households were sampled at random until 25 partici-
pants were included. Verbal informed consent was
obtained from all household members >16 years old to
participate in the survey. For persons ≤  16 years old,
informed consent was obtained from a parent or guard-
ian. For each participant, basic demographic data were
collected, as well as the number of injections received dur-
ing the 6 month period beginning on April 13, 2002 (New
Year's Day in Cambodia). Injections were categorized as
therapeutic injections, immunizations, and intravenous
infusions. Participants >16 years of age were also inter-
viewed regarding their knowledge and attitudes about
injections.
Prescribers and injection providers
We surveyed prescribers and injection providers in Takeo
province and Phnom Penh in November and December
2002. In Takeo province, a convenience sample of 30 pre-
scribers and 30 injection providers was accessed through
the province's five public hospitals. In Phnom Penh, 30
prescribers were randomly selected from a list of regis-
tered private outpatient clinics and 30 injection providers
were selected from 11 of the city's 13 private hospitals. For
all prescribers, regardless of where they were identified,
the survey focused on their medical practices in their pri-
vate outpatient clinics. We ascertained their knowledge,
attitudes and practices regarding injections. Injection fre-
quency was determined by asking prescribers to estimate
the total number of prescriptions they wrote per week and
the number that included an injection or infusion. Injec-
tion providers were interviewed regarding their knowl-
edge of disease transmission risks through unsafe
injections, their hepatitis B vaccination status and the fre-
quency of needle stick injuries during the previous 12
months. In addition, we observed each injection provider
administer one injection. During all hospital visits, infor-
mation was recorded regarding the use of incinerators and
the presence of used needles and syringes and other med-
ical equipment on the grounds of the facility.
Data analysis
Proportions, means, and confidence intervals were calcu-
lated using EpiInfo 6.04d (CDC, Atlanta, Georgia) with
adjustment for the cluster sampling design effect. Univar-
iate and multivariate analyses of variables associated withBMC Public Health 2005, 5:56 http://www.biomedcentral.com/1471-2458/5/56
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receiving injections were performed using SAS software
version 8 (SAS Institute, Cary, North Carolina).
Results
General population
The overall injection rate was 5.9 injections per person-
year (95% CI: 5.3 – 6.7), with 40% of the participants
reporting receipt of one or more injections during the pre-
vious 6 months (Table 1). Therapeutic injections
accounted for 74% of the total number of injections
reported, followed by intravenous infusions (16%), and
immunization (10%). Among individuals who had any
exposure to injections, nearly one-half reported receiving
≥  5 injections. This group represented only 18% of all par-
ticipants but accounted for 69% of the total injections
reported.
The pattern of injection use differed by age and sex.
Among adults, women were more likely than men to
report receiving any (42% vs. 28%, p < 0.001) or frequent
injections (i.e., ≥  5 injections during the previous 6
months; 22% vs. 9%, p < 0.001) (Table 1). Women were
also more likely than men to report having received ≥  1
therapeutic injection (39% vs. 20%, p = 0.001). Similar
proportions of men, women and children reported receiv-
ing intravenous infusions, ranging from 14 – 18%. Immu-
nizations were limited to children, with 35% of children
reporting having received ≥  1 immunization.
Ninety-six adult participants (93% of those reporting one
or more injection in the previous 6 months) could recall
the details of their last injection. All reported the injection
was administered with a newly opened disposable syringe
and needle. The majority (85%) of these injections was
administered by health care workers; at least 13% were
administered by lay persons (Figure 1). Injections were
most commonly administered in the patient's home
(65%) or in a private clinic (20%). Only 13% of injections
were administered at public hospitals or public health
centers.
Of the 288 subjects interviewed, 90% reported they would
trust a medical practitioner who did not prescribe an
injection (Table 1). However, 47% (134/288) believed
that therapeutic injections are more powerful than oral
medications, with 75% (100/134) of these persons attrib-
uting a faster healing effect to injections. In addition, 32%
of the respondents reported they preferred injections over
oral medications for the treatment of illnesses character-
ized by fever. Knowledge of the HIV transmission risk
associated with "dirty" syringes and needles was very high
(95%), though only 59% of respondents were aware that
hepatitis could be transmitted in this manner. None of the
knowledge or attitude variables or other characteristics
(besides gender) were associated with the receipt of injec-
tions. This was true even when the analyses were restricted
to comparisons of persons reporting no injections versus
frequent injection use (i.e., ≥  5 injections during the pre-
vious 6 months).










median 22 9 38 37
range (years) 0–80 0–16 17–79 17–80
Injection experiences (6-month period)
Number of injections 1483 557 713 213
Overall injection rate (per person-year) 5.9 5.3 7.5 4.3
Proportions of subjects who received:
≥  1 vaccine injection 15% 35% 0% 0%
≥  1 therapeutic injection 32% 31% 39% 20%
≥  1 intravenous infusion 16% 16% 18% 14%
≥  1 injection (any type) 40% 46% 42% 24%
≥  5 injections (any type) 18% 18% 22% 9%
Knowledge and attitudes^
Trusted practitioners if no injections prescribed 90% ND 90% 89%
Preferred injection for treatment of fever 32% ND 35% 26%
Believed injections more powerful than oral medication 47% ND 50% 40%
Aware that dirty syringes can transmit HIV 95% ND 96% 93%
Aware that dirty syringes can transmit hepatitis 59% ND 60% 57%
ND = not determined
* participants aged ≤  16 years
^ adults only (288 total respondents)BMC Public Health 2005, 5:56 http://www.biomedcentral.com/1471-2458/5/56
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Prescribers
The 60 prescribers interviewed were registered medical
doctors or medical assistants. Prescribers estimated that
nearly half (47%) of the total prescriptions they wrote
included either a therapeutic injection (34%) or an intra-
venous infusion (14%) (Table 2). The overall prescription
rates and distribution by type was similar in Phnom Penh
and Takeo Province. The main reasons cited for prescrib-
ing injections were illness severity (44%) and perceived
patient preferences for injectable medications (40%). Sev-
enty-seven percent of prescribers believed that injection
prescriptions resulted in greater reimbursement. Only one
prescriber perceived himself as over-prescribing injec-
tions. Most (92%) prescribers were aware that HIV, HBV
and HCV could be transmitted through unsafe injections
(Table 2).
Injection providers
All 60 injection providers interviewed were registered
nurses, only 20% of whom had received the complete
hepatitis B vaccination series. During our observations, 59
(98%) providers used new single use syringes (i.e., tradi-
tional plastic disposable syringes) and needles and one
administered the injection with sterilized reusable equip-
ment. Over half (58%) of the providers were observed
practicing two-handed recapping of used injection equip-
ment and 53% reported they had sustained a needlestick
injury during the past 12 months. For only 25% of provid-
ers, a safety box (i.e. sharps container) was observed in
close proximity to the injection area, yet 85% reported
having a sufficient number of safety boxes. We observed
that 13% of providers left used sharps in the injection
preparation area (23% in Takeo province and 3% in
Phnom Penh city). Ninety percent of injection providers
stated they were aware that HIV, HBV and HCV could be
transmitted through unsafe injections (Table 2).
Waste disposal
In the general population survey in Takeo province, 32%
(23/72) of participants who reported receiving their last
injection in their home reported that the used injection
equipment was left behind by the injection provider.
Used sharps were observed on the grounds outside three
of the five public hospitals in Takeo province, but not on
the grounds of any of the 11 private hospitals in Phnom
Penh. Incinerators and sharps pits in which used sharps
waste could be burned or buried were present at all of the
Takeo hospitals. In Phnom Penh, sharps pits were availa-
ble in two hospitals. In the remaining nine hospitals,
sharps waste was collected along with non-medical waste
for disposal at the city landfill.
Discussion
The rapid assessment of injection practices described in
this paper suggests that injections are prescribed and
administered in Cambodia at excessive rates. Intravenous
infusions were common among the general population
surveyed and represented approximately one-third of all
Distribution of injections by provider type and setting*, Takeo Province, Cambodia, 2002 (n = 96) Figure 1
Distribution of injections by provider type and setting*, Takeo Province, Cambodia, 2002 (n = 96) *Data refer to the most 
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injections prescribed in private outpatient clinics. Using
WHO standardized measures as a basis for comparison,
our assessment indicates that Cambodia has one of the
highest rates of overall therapeutic injection usage ever
reported worldwide [1,2]. Studies conducted in other
countries in the region have documented rates of 2–4
injections/person/year; approximately one third lower
than in Cambodia [2].
This assessment documented potentially harmful injec-
tion practices including inadequate handling and disposal
of used injection equipment. Given the country's high
prevalence of HIV, HBV, and HCV, the overuse and mis-
use of injections carry substantial risks. While reuse of
injection equipment was uncommon in this survey, the
high prevalences of bloodborne infections may reflect
past practices of needle and syringe reuse. We did observe
breaks in aseptic technique (e.g., used sharps left in the
injection preparation area) that may facilitate cross-con-
tamination during injection preparation [13,14]. Other
infection control breaks such as mishandling of sterile
materials and improper use of multidose vials have been
frequently implicated in the transmission of bloodborne
viral and bacterial infections, but were not studied in this
survey [13,15]. Anecdotal reports suggest that used nee-
dles and syringes might be repackaged and resold as new.
While there was no evidence to suggest this practice was
occurring in Cambodia, we did not evaluate the sterility of
needles and syringes. In addition, many of the injection
providers in our survey engaged in high risk behaviors
(e.g., two-handed recapping needle), highlighting the










Medication prescription rate (prescriptions/week)
average 20 21 20
median 20 21 20
range 4–140 4–140 7–140
Prescriptions including an injection2 47% 48% 45%
therapeutic injection 34% 32% 35%
intravenous infusion 14% 18% 10%
Main reason for prescribing injections
illness severity 44% 50% 37%
patient preference 40% 40% 40%
more effective than oral medications 12% 7% 17%
reimbursement 9% 7% 10%
Preferred injectable med for treatment of febrile illness 64% 47% 80%
Believed patient trust requires injection prescription 42% 53% 30%
Believed reimbursement is higher for patient visits that result in injection prescription 77% 87% 66%
Perceived themselves as over-prescribing injections 2% 3% 0%
Knew HIV, HBV and HCV can be transmitted through unsafe injections 92% 87% 97%
Characteristics of injection providers
Completed hepatitis B vaccination series 20% 7% 33%
Needlestick injury in last 12 months 53% 50% 57%
Average number (and range) of needlesticks in past 12 months among those reporting one or more 1.7 (1–10) 1.4 (1–6) 2.0 (1–10)
Use of single use needles and syringes3 98% 97% 100%
Safety box (i.e., sharp container) present in injection administration area3 25% 37% 13%
Reported having sufficient number of sharps boxes 85% 77% 93%
Practiced two hand recapping of used needles3 58% 53% 60%
Left used sharps in preparation area3 13% 23% 3%
Knew HIV, HBV and HCV can be transmitted through unsafe injections 90% 87% 93%
1 Prescribers' responses pertain to their private outpatient practices
2 Denominator is the total number of weekly prescriptions
3 Based on observation of provider by the investigatorsBMC Public Health 2005, 5:56 http://www.biomedcentral.com/1471-2458/5/56
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need for training and other interventions aimed at reduc-
ing occupational exposures and infection risks.
The patterns of attitudes, knowledge and practices regard-
ing injections among the general population and health
professionals observed in Cambodia were similar to those
in many countries with high frequencies of injections and
comparable healthcare systems such as Pakistan, India,
and Indonesia [16-18]. In these countries as in Cambodia,
patients and prescribers frequently believe that injections
are more effective than oral treatments, and few health
professionals perceive themselves as over-prescribing
injections. This study and others have also shown that
many healthcare providers believed that patients' trust
hinged on injection prescriptions, whereas only a minor-
ity of patients actually stated that they prefer injections for
treatment of conditions that could be treated with oral
medications. Both misconceptions may facilitate injec-
tion overuse.
In this study, almost half of the prescriptions made by the
private providers we surveyed contained at least one injec-
tion, compared with a previous finding that only 2% of
prescriptions written in public sector outpatient clinics
included injections [19]. Financial interests might lead
some private health professionals to over-prescribe inject-
able medications [16]. Since oral and intravenous medica-
tions are readily available directly from pharmacies
without prescriptions, it is possible that private healthcare
providers provide and promote injections and infusions
as a way to attract patients [20]. These factors might partly
explain the popularity of the private sector compared with
the public healthcare sector where the cost for clinic visits
is lower and medications are available free of charge, but
are dispensed according to standardized treatment proto-
cols which generally specify oral formulations.
High levels of awareness of infection risks associated with
syringe and needle reuse, particularly regarding HIV were
documented in this study. This is consistent with results of
a recent national Demographic Health Survey [9] and
likely reflects Cambodia's efforts during the late 1990's to
educate the general public regarding risk factors for HIV
infection. These education campaigns included informa-
tion on the risk of transmission of HIV from re-used
syringes. Following the campaigns, disposable needles
and syringes became widely available in Cambodia at a
relatively low cost. It is possible that the increased aware-
ness of HIV infection risks associated with injections led
to increased utilization of disposable needles and syringes
rather than a shift toward alternative forms of treatment.
This assessment had several limitations. First, the survey
did not capture the medical indications that were
associated with either prescription or receipt of injections.
Second, resource constraints required the general popula-
tion surveys to focus on one province instead of being
conducted nationwide. Takeo province was selected
because it is the third most populated province, its eco-
nomic status is in the middle of the national spectrum,
and like the general Cambodian population it is mainly
rural [9]. Third, because only formal health professionals
were surveyed, we could not assess practices in the infor-
mal health sector. We found that approximately one-in-
seven injections in Takeo province were administered by
untrained paramedical and lay health care workers and
their practices may differ from health care workers in the
formal sector.
There is growing consensus that improvements in injec-
tion safety and overuse in developing countries can be
achieved [21]. Such efforts require multidisciplinary
engagement and behavioral changes on the parts of both
patients and health professionals, including those from
the private healthcare sector [22]. Although large-scale
interventions to improve the safety of therapeutic injec-
tions are limited, several demonstration projects have
proven to be effective and relatively long lasting. Studies
in Indonesia demonstrated a sustained 19% reduction in
injection rates following "interactional group discus-
sions," an intervention that brings health care providers
and patients together to discuss their preferences regard-
ing injections and oral medications [18,23]. In Burkina
Faso, interventions targeted at providing sufficient quan-
tities of single-use syringes and needles resulted in >90%
reductions in unsafe injections that have been sustained
for at least 5 years [24].
Comprehensive interventions aimed at reducing overuse
of injections, promoting rational use of oral and injecta-
ble medications, and reinforcing safe injection and waste
disposal practices are likely to be cost-effective in Cambo-
dia [25,26]. While initial efforts in injection safety have
been largely focused on infant immunization, Cambodia
is now expanding this initiative to include curative care,
with an emphasis on the private sector. A national plan of
action has been developed to decrease injection use and
promote injection safety in accordance with WHO guide-
lines. The plan aims to involve multidisciplinary partners
and improve coordination among relevant departments
in the Ministry of Health. This plan also includes demon-
stration projects that address specific issues related to
injection use in the private sector. It is hoped that Cambo-
dia's efforts to address its injection safety and overuse
problems will provide an example for other countries that
are beginning to confront this important public health
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